Novel synthesis of neokotalanol improves α-glucosidase inhibition in biological models, suggesting effective therapeutic potential.
A novel synthesis of neokotalanol, a sulfonium type α-glucosidase inhibitor derived from the genus Salacia, was developed. The strategy efficiently constructs the d-manno-heptitol side chain from 2-hydroxyglycal via cyclopropanation and ring-opening reaction. Stereoselective borohydride reduction of a 2,3-dicarbonyl intermediate installed two key chiral hydroxy groups. This Wittig-free method uses nontoxic reagents and achieves gram-scale synthesis of a key intermediate, enabling its first structural modification that highlights the critical role of C-6′ hydroxyl for biological activity.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: